在发现和开发针对抗癌活性的蛋白激酶抑制剂 (PKI) 中应用基于人工智能的方法
Emanuelly Karla Araújo Padilha1, Wadja Feitosa Dos Santos Silva1, Arestides Alves Lins1
1Research Group of Biological and Molecular Chemistry, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Lourival Melo Mota Avenue, AC. Simões Campus, 57072-970 Alagoas, Maceió, Brazil.
人工智能 (AI) 加快了用于癌症治疗的蛋白激酶抑制剂 (PKI) 的发现. 机器学习和深度神经网络通过快速分析化合物和改进目标识别来增强药物设计.
科学领域:
- 药用化学 医学化学
- 计算生物学 计算生物学
- 人工智能在药物发现中的作用
背景情况:
- 蛋白激酶抑制剂 (PKI) 在抗癌药物开发中至关重要.
- 传统的药物查方法耗时且效率较低.
- 需要先进的计算工具来加快有效PKI的识别.
研究的目的:
- 审查人工智能 (AI) 方法在开发抗癌活性PKI中的应用.
- 突出AI在预测活性化合物和优化药物设计方面的作用.
- 讨论PKI发现人工智能驱动方法的最新进展.
主要方法:
- 审查使用机器学习 (ML),深度神经网络 (DNN) 和定量结构-活动关系 (QSAR) 进行PKI识别的研究.
- 分析基于人工智能的策略,用于复合选,数据集增强和目标识别.
- 探索用于创建新型化合物的生成模型和用于数据库挖掘的ML.
主要成果:
- 与传统方法相比,人工智能显著加快了潜在抑制剂的分析.
- 人工智能工具通过预测活性化合物和优化数据集来提高药物设计和开发的效率.
- 深度学习和QSAR模型在识别新型PKI方面表现有前途.
结论:
- 基于人工智能的工具正在彻底改变用于癌症治疗的蛋白激酶抑制剂的开发.
- 人工智能为药物化学中的药物发现提供了强大而高效的替代方案.
- 人工智能的持续进步预计将进一步提高识别向抗癌剂的成功率.
更多相关视频
12:40A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Protein-protein Interfaces
Targeted Cancer Therapies
There are several types of targeted therapies against...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview
